CircPTPRA competitively binds to the KH domain of IGF2BP1, interfering with its interaction with the downstream targets Myc and FSCN1 mRNA, thus inhibiting the growth and invasiveness of breast cancer cells [155]. The gene discussed is IGF2BP1; the disease is breast cancer.